ORGO NASDAQ
Organogenesis Holdings Inc.
1W: -5.7%
1M: -20.4%
3M: -46.4%
YTD: -71.3%
1Y: -69.0%
3Y: -58.2%
5Y: -91.1%
$1.33
-0.07 (-5.00%)
Weekly Expected Move ±7.1%
$1
$1
$1
$1
$2
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
6 relationships6
As Filer
counterparties named
0
As Counterparty
mentioned by others
3
Rel. Types
2024-11-13
Earliest Filing
2025-12-29
Latest Filing
partner: 3
investor: 2
customer: 1
Counterparties (Filed by ORGO)
6 relationshipsCompanies named in ORGO's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| 65 Dan Road SPE, LLC | — | partner | Landlord for the 65 Dan Road property lease amendment. | 2025-12-29 | View |
| Dan Road Associates, LLC | — | partner | Landlord for the 150 Dan Road property lease amendment. | 2025-12-29 | View |
| DIV Technology Way, LLC | — | partner | Landlord for the lease of 122,000 square feet of manufacturing space in Smithfield, Rhode Island. | 2024-11-22 | View |
| Avista Healthcare Partners III, L.P. | AVA | investor | Investor in the $130 million private placement of Series A Convertible Preferred Stock | 2024-11-13 | View |
| AHP III Orchestra Holdings, L.P. | — | investor | Investor in the $130 million private placement of Series A Convertible Preferred Stock | 2024-11-13 | View |
| RED Holdings, LLC | RDDT | customer | Stockholder from whom the Company repurchased 590,332 shares of Common Stock | 2024-11-13 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-08-06 | Earnings Release; Exhibits | View | |
| 2026-08-06 | Material Agreement; Exhibits | Agreement | View |
| 2026-06-16 | Officer/Director Change; Shareholder Vote | View | |
| 2026-05-07 | Earnings Release; Exhibits | View | |
| 2026-02-26 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2026-02-23 | Departure/Election of Directors; Appointment of Officers | View | |
| 2025-12-29 | Entry into Material Definitive Agreement; Financial Statements and Exhibits | Agreement | View |
| 2025-11-06 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-09-25 | Regulation FD Disclosure; Other Events; Financial Statements and Exhibits | View | |
| 2025-08-07 | Entry into Material Definitive Agreement; Results of Operations and Financial Condition; Financial S | Agreement | View |
| 2025-06-24 | Departure/Election of Directors; Appointment of Officers; Submission of Matters to a Vote of Securit | View | |
| 2025-05-08 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-03-27 | Regulation FD Disclosure; Financial Statements and Exhibits | View | |
| 2025-02-27 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2024-12-02 | Entry into Material Definitive Agreement; Financial Statements and Exhibits | Agreement | View |
| 2024-11-22 | Entry into Material Definitive Agreement; Other Events; Financial Statements and Exhibits | Agreement | View |
| 2024-11-13 | Entry into Material Definitive Agreement; Triggering Events That Accelerate Obligation; Unregistered | Agreement | View |
| 2024-11-12 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2024-05-09 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2024-04-03 | Other Events | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR